Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Businesses face an increasingly complex framework of established and evolving legislation and regulations concerning civil, criminal and regulatory risks.
Our Regulatory, compliance and investigations hub on NRF Institute provides clients with access to the latest news and insights to help them navigate the legal, procedural, governance and reputational aspects of regulatory and compliance issues, investigations and litigation worldwide.
Register for the hub
To request access to the 'Regulatory, compliance and consulting hub', please register to join NRF Institute.
Registration indicates acceptance of the terms and conditions which include important information about how our product will be delivered.
Members of the NRF Institute can access a range of premium content including knowledge hubs and cross-border guides.
Head of Dispute Resolution and Litigation, EMEA
Email
patrick.bourke@nortonrosefulbright.com
Global Co-Head of International Arbitration
Email
ruth.cowley@nortonrosefulbright.com
Partner
Email
alexander.cappel@nortonrosefulbright.com
Head of White Collar Defense and Investigations, United States
Email
kevin.harnisch@nortonrosefulbright.com
Global Head of Financial Services
Email
jonathan.herbst@nortonrosefulbright.com
Partner
Email
abigail.mcgregor@nortonrosefulbright.com
Head of Investigations, Amsterdam
Email
sharon.oded@nortonrosefulbright.com
Head of Risk Advisory, United States
Email
keith.rosen@nortonrosefulbright.com
Recent publications
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .